Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 3, 2016
[ 07:47 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
Tyler Van Buren Initiated (TBPH) at Buy on, Nov 3rd, 2016
Tyler Van Buren of Piper Sandler, Initiated "Theravance Biopharma, Inc." (TBPH) at Buy on, Nov 3rd, 2016.
Tyler has made no other calls on TBPH in the last 4 months.
There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Tyler's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tyler
- Josh Schimmer of "Evercore ISI Group" Initiated at Strong Buy and Held Target at $41 on, Monday, August 29th, 2016
